bovinederiv
crosslink
stabil
hemoglobin
kda
physiolog
salin
daili
intraven
infus
hboc
gkgday
gestat
day
gd
spraguedawley
rat
caus
fetal
mortal
reduc
birth
weight
malform
subsequ
singleday
infus
gkgday
show
development
toxic
limit
gd
histiotroph
nutrit
via
invert
viscer
yolk
sac
invvi
essenti
histiotroph
nutrit
receptormedi
endocytosi
bulk
matern
protein
subsequ
lysosom
degrad
provid
amino
acid
nutrient
embryon
growth
control
protein
content
oncot
properti
hemoglobin
content
indic
toxic
due
hemoglobin
rat
whole
embryo
cultur
verifi
hboc
interfer
invvi
transport
capac
result
defici
embryon
nutrit
mechan
action
expect
impact
human
develop
base
differ
vy
morpholog
function
although
complet
understand
earli
human
embryon
nutrit
lack
blood
transfus
frequent
lifesav
procedur
receiv
nearli
million
peopl
year
current
blood
suppli
sole
depend
upon
volunt
donat
popul
potenti
donor
recent
decreas
due
stricter
requir
necessari
keep
blood
suppli
safe
instanc
sever
acut
respiratori
syndrom
sar
bovin
spongiform
encephalopathi
detect
abroad
individu
frequent
travel
deem
unfit
donat
prolong
period
time
unfortun
result
blood
suppli
danger
low
thu
acut
need
human
blood
substitut
hemoglobinbas
oxygen
carrier
hboc
promis
class
blood
substitut
current
develop
intraven
administr
patient
suffer
anemia
andor
blood
loss
use
dual
purpos
expand
blood
volum
act
oxygenbridg
agent
substanc
use
experi
deriv
bovin
hemoglobin
thoroughli
purifi
remov
bacteria
virus
nativ
form
bovin
hemoglobin
noncoval
bound
tetram
total
molecular
weight
da
kda
form
coval
bond
four
coval
stabil
tetram
result
polymer
hemoglobin
molecul
exhibit
mean
molecular
weight
da
observ
made
pilot
studi
infus
includ
resorpt
occur
earli
implant
later
rais
question
appropri
rodent
model
human
risk
assess
purpos
set
studi
report
ascertain
character
matern
particularli
development
toxic
associ
intraven
infus
pregnant
rat
understand
toxicolog
properti
sensit
period
provid
insight
particular
gestat
mechan
like
underli
observ
effect
intrins
physicochem
characterist
intend
use
pose
signific
challeng
design
ration
dose
protocol
toxicolog
studi
high
concentr
protein
oncot
properti
larg
inject
volum
initi
experi
examin
development
toxic
result
dose
gkgday
chosen
repres
multipl
highest
propos
human
dose
given
one
day
infus
gestat
day
gd
treatment
period
encompass
major
organogenesi
rat
treatment
associ
embryoleth
high
malform
rate
initi
experi
experi
pregnant
rat
perform
order
identifi
specif
sensit
period
organogenesi
infus
produc
pronounc
development
toxic
addit
studi
perform
order
investig
whether
chang
osmot
pressur
properti
compon
relat
hemoglobin
andor
increas
oxid
stress
underli
factor
might
explain
exacerb
observ
toxic
development
toxic
present
dam
intraven
infus
gd
rang
period
invert
viscer
yolk
sac
invvi
provid
primari
sourc
embryon
nutrit
supplementari
experi
whole
embryo
cultur
conduct
determin
interfer
normal
endocytot
function
invvi
rodent
continu
singleday
infus
studi
perform
clintrial
bioresearch
ltd
laboratori
ctbr
quebec
canada
hemodilut
studi
perform
wil
research
laboratori
inc
wil
ashland
ohio
techniqu
use
two
laboratori
compar
variat
note
facil
accredit
associ
assess
accredit
laboratori
anim
care
intern
anim
maintain
accord
principl
set
forth
guid
care
use
laboratori
anim
femal
spraguedawley
crl
cd
sd
br
rat
appar
good
health
receiv
charl
river
breed
laboratori
kingston
ny
portag
mi
rat
individu
hous
stainless
steel
wiremesh
cage
temperatur
humid
control
room
maintain
h
h
dark
cycl
anim
given
time
acclim
environ
provid
ad
libitum
access
food
water
start
treatment
anim
wk
old
mate
anim
one
femal
place
one
proven
male
strain
sourc
femal
examin
daili
evid
mate
detect
copulatori
plug
vagina
andor
examin
vagin
lavag
spermatozoa
day
posit
identif
copul
consid
gd
femal
assign
experiment
group
use
computerbas
random
procedur
provid
homogen
group
mean
varianc
bodi
weight
end
experi
anim
human
euthan
co
asphyxi
infus
vehicl
salin
control
consist
sodium
chlorid
solut
baxter
healthcar
corpor
deerfield
il
store
room
temperatur
solut
gdl
salin
prepar
biopur
cambridg
solut
human
serum
albumin
hsa
salin
pharmacia
upjohn
inc
kalamazoo
mi
use
control
protein
content
control
colloid
composit
solut
hetastarch
salin
dupont
wilmington
de
colloid
properti
similar
use
addit
control
hemoglobin
content
perform
use
purifi
bovin
hemoglobin
pbh
gdl
isoton
salin
trisacet
buffer
ph
biopur
asept
techniqu
appli
fill
syring
infus
surgic
implant
cathet
perform
nonpregn
gd
anim
ctbr
anim
anesthet
ether
wil
anim
anesthet
use
mixtur
ketamin
hcl
xylazin
mlkg
anim
remain
anesthesia
entir
surgic
procedur
small
incis
made
groin
region
femor
vein
isol
medic
grade
silast
cathet
insert
cathet
secur
place
sutur
materi
exterior
via
trocar
shoulder
blade
jacket
place
anim
hold
tether
system
constant
infus
sodium
chlorid
approxim
mlh
initi
treatment
kept
cathet
patent
topic
antibiot
administ
daili
cathet
exterior
site
femor
site
consid
unnecessari
continu
infus
studi
anim
assign
gkgday
group
well
salin
gkgday
hetastarch
control
group
follow
implant
cathet
rat
receiv
continu
intraven
infus
morn
gd
morn
gd
rat
weigh
gd
infus
rate
base
recent
bodi
weight
anim
infus
interrupt
weigh
similarli
singleday
infus
studi
six
anim
assign
gkgday
salin
gkgday
hetastarch
control
group
except
salin
control
anim
rat
receiv
intraven
infus
singl
period
approxim
h
start
morn
gd
salin
control
rat
continu
infus
salin
gd
continu
singleday
studi
dose
volum
mlkg
salin
hsa
hetastarch
administ
day
administ
dose
volum
mlkg
day
gkgday
group
respect
colloid
administ
larg
volum
pregnant
rat
experi
reduc
likelihood
fluid
overload
attend
advers
consequ
pulmonari
edema
hypertens
hemodilut
procedur
develop
blood
volum
anim
remov
immedi
prior
infus
test
materi
hemodilut
procedur
illustr
fig
follow
mate
group
eight
anim
assign
salin
control
group
use
hemodilut
studi
perform
assess
whether
anemia
osmot
pressur
hetastarch
use
control
oncot
effect
osmol
hetastarch
mom
osmol
calcul
mosm
due
molecular
weight
differ
hboc
approxim
kd
hetastarch
approxim
kd
mlkg
high
dose
result
g
hbockg
wherea
ml
hetastarch
result
gkg
chang
contribut
development
toxic
test
control
rat
given
dose
mlkg
salin
administ
via
indwel
cathet
twice
gd
morn
gd
rate
approxim
mlmin
dose
salin
addit
mainten
salin
administ
cannular
patenc
gd
dose
salin
administ
oral
hemodilut
procedur
target
decreas
hemoglobin
infus
conduct
afternoon
gd
wherein
anim
administ
ml
salin
via
indwel
cathet
rate
mlmin
prior
place
incub
approxim
c
min
allow
vein
dilat
anim
remov
incub
place
restrain
connect
infus
pump
administ
salin
rate
approxim
mlmin
via
indwel
cannula
simultan
blood
slowli
withdrawn
use
heparin
temporari
indwel
cathet
gaug
place
later
tail
vein
blood
withdraw
tail
stroke
caudal
direct
assist
blood
flow
target
blood
withdraw
volum
ml
rate
approxim
mlmin
total
amount
infus
given
control
anim
indwel
cathet
three
time
total
volum
withdrawn
blood
infus
occur
two
phase
first
phase
mlkg
administ
rate
approxim
mlmin
approxim
onehour
infus
period
volum
first
phase
infus
record
second
phase
made
salin
infus
rate
mlmin
total
volum
salin
plu
phase
infus
total
three
time
volum
blood
withdrawn
tail
vein
control
anim
receiv
salin
phase
infus
rat
remov
restraint
return
cage
reconnect
tether
system
hemoglobin
valu
measur
use
hemocu
derbyshir
uk
hemoglobin
instrument
prior
hemodilut
procedur
upon
complet
blood
removalinfus
administr
approxim
h
complet
infus
administr
follow
euthanasia
dam
gd
reproduct
tract
excis
ovari
remov
corpora
lutea
count
gravid
uteru
weigh
uterin
content
includ
placenta
examin
number
posit
live
fetus
dead
fetus
earli
late
resorpt
record
earli
resorpt
defin
nonviabl
embryo
discern
featur
head
limb
late
resorpt
defin
nonviabl
fetus
discern
featur
indic
autolysi
uteru
anim
pregnant
time
necropsi
stain
aqueou
vv
ammonium
sulfid
solut
examin
implant
site
describ
salewski
viabl
fetus
weigh
sex
given
detail
extern
examin
live
fetus
euthan
subcutan
inject
euthanasia
solut
intrathorac
inject
sodium
pentobarbit
detail
examin
includ
limit
eye
palat
extern
orific
extern
find
record
development
variat
malform
development
variat
includ
alter
anatom
structur
consid
signific
biolog
effect
anim
health
bodi
conform
malform
includ
structur
chang
alter
gener
bodi
conform
disrupt
interfer
bodi
function
gener
thought
incompat
life
percentag
malform
fetus
litter
fetus
malform
determin
statist
analysi
perform
parametr
data
bodi
weight
data
use
one
way
anova
dunnett
post
hoc
test
statist
signific
p
result
statist
analysi
nonparametr
data
group
mean
live
litter
size
calcul
use
kruskalw
test
statist
signific
result
found
p
mannwhitney
u
test
use
analyz
differ
control
test
group
anim
deem
nongravid
treat
accord
studi
protocol
exclud
analysi
spraguedawley
rat
use
whole
embryo
cultur
studi
timem
univers
michigan
reproduct
scienc
program
small
anim
core
morn
mate
vagin
smear
perform
sperm
detect
anim
consid
rat
receiv
gd
fluorescein
isothiocyan
fitcalbumin
mol
fitcmol
albumin
obtain
sigma
chemic
compani
st
loui
mo
embryo
cultur
reagent
obtain
gibco
brl
gaithersburg
md
penicillin
uml
streptomycin
sulfat
uml
obtain
invitrogen
co
grand
island
ny
suppli
biopur
reagent
highest
qualiti
commerci
avail
gd
uteri
remov
pregnant
dam
conceptus
dissect
uteru
prepar
cultur
describ
previous
conceptus
appropri
stage
somit
elev
open
neural
tube
dorsal
flexur
cultur
medium
consist
heatinactiv
rat
serum
hank
balanc
salt
solut
hbss
plu
penicillinstreptomycin
lml
allow
least
ml
medium
per
conceptu
cultur
medium
headspac
warm
c
satur
min
co
n
cultur
conceptus
allow
equilibr
cultur
condit
roller
incub
c
h
untreat
medium
expos
one
follow
procedur
simultan
exposur
conceptus
fitcalbumin
allow
determin
whether
affect
endocytosi
follow
equilibrium
period
conceptus
cultur
addit
h
fresh
control
medium
medium
contain
concentr
rang
vv
plu
fitcalbumin
gml
medium
sampl
l
l
taken
begin
end
fitcalbumin
exposur
cultur
conceptus
remov
process
fitcalbumin
analysi
describ
protein
content
measur
method
bradford
modifi
harri
et
al
bovin
gamma
globulin
biorad
use
standard
slight
modif
need
assay
invvi
see
dna
content
measur
fluorometr
method
labarca
paigen
use
bovin
dna
standard
complet
cultur
treatment
conceptus
remov
cultur
process
previous
describ
ambroso
et
al
follow
overview
assay
slight
modif
conceptus
rins
transfer
drop
sodium
phosphat
buffer
mm
two
conceptus
per
l
drop
conceptus
dissect
drop
releas
extraembryon
fluid
eef
contain
invvi
amnion
drop
transfer
microcentrifug
tube
eef
also
contain
small
amount
concept
blood
leak
collect
fluid
invvi
place
cold
triton
previou
experiment
confirm
signific
amount
intact
fitcalbumin
fitc
bound
peptid
fragment
form
solubil
fitc
reach
embryo
proper
procedur
embryo
therefor
discard
includ
subsequ
analys
invvi
sonic
l
taken
sampl
protein
determin
method
describ
bradford
modifi
harri
et
al
protein
precipit
eef
invvi
l
media
sampl
ad
l
trichloroacet
tca
determin
total
fitcalbumin
l
media
sampl
protein
solubil
use
l
tca
contain
sodium
dodecyl
sulfat
sd
sampl
refriger
overnight
h
fulli
precipit
solubil
protein
respect
centrifug
g
min
remov
supernat
contain
acid
solubl
albumin
fragment
one
millilit
mm
tri
buffer
l
n
naoh
ad
acidsolubl
supernat
sampl
approxim
ph
quantifi
perkinelm
model
ls
fluoresc
spectrophotomet
nm
excit
nm
emiss
nm
slit
width
scale
one
hundredfifti
ml
n
naoh
ad
pellet
contain
acid
insolubl
albumin
pellet
allow
dissolv
room
temperatur
h
one
millilit
mm
tri
l
triton
l
tca
ad
acidinsolubl
pellet
solubil
materi
analyz
fluoresc
gsh
resolv
quantifi
monobromobiman
mbbr
deriv
use
high
perform
liquid
chromatograph
hplc
method
describ
modifi
fahey
newton
briefli
viscer
yolk
sac
rins
free
cultur
media
cold
phosphat
buffer
salin
pb
hbss
place
microcentrifug
tube
contain
l
methanesulfon
acid
msa
mm
sampl
frozen
immedi
liquid
nitrogen
store
c
prepar
hplc
thaw
sampl
homogen
ultrason
disrupt
l
sodium
methanesulfon
ad
sampl
centrifug
g
pellet
precipit
protein
supernat
transfer
clean
microcentrifug
tube
follow
compon
ad
success
l
mm
heppsmethanesulfon
ph
l
mm
diethylenetriaminepentaacet
acid
dtpa
l
mm
mbbr
sampl
mix
allow
react
dark
min
c
follow
addit
l
mm
msa
reacidifi
sampl
prior
storag
c
sampl
remain
stabl
condit
month
hplc
analys
carri
use
water
novapak
c
radialpak
cartridg
preced
novapak
guardpak
guard
column
column
equilibr
sampl
elut
isocrat
mobil
phase
consist
methanol
vv
glacial
acet
acid
adjust
ph
flow
rate
mlmin
run
column
wash
reequilibr
min
regener
mobil
phase
consist
methanol
glacial
acet
acid
detect
quantit
bimanegsh
accomplish
use
water
model
scan
fluoresc
detector
excit
nm
emiss
nm
follow
peak
record
analysi
use
water
model
data
modul
overal
differ
among
treatment
mean
assess
oneway
analysi
varianc
anova
signific
differ
present
pairwis
comparison
analyz
fisher
protect
least
signific
differ
test
differ
consid
statist
signific
p
matern
development
toxic
data
pregnant
femal
rat
continu
infus
gkgday
hsa
salin
treatment
gd
summar
tabl
comparison
salin
control
infus
dam
dosag
group
exhibit
reduct
matern
weight
gain
one
femal
gkgday
treat
group
euthan
gd
due
overt
discomfort
anoth
femal
group
found
dead
gd
gross
patholog
chang
suggest
cardiac
insuffici
anim
overt
sign
matern
toxic
observ
group
includ
petechi
hemorrhag
tail
darken
eye
andor
skin
onset
occurr
observ
doserel
mean
number
viabl
fetus
per
litter
significantli
decreas
dosedepend
manner
follow
infus
anim
treat
gkgday
bore
averag
live
fetus
per
litter
respect
doserel
decreas
fetal
bodi
weight
follow
administr
observ
gkgday
group
decreas
statist
signific
mgkgday
group
percentag
fetus
litter
extern
malform
gkgday
group
fetus
dam
gkgday
group
exhibit
extern
malform
predomin
fetal
malform
seen
gkgday
group
includ
anophthalmiamicrophthalmia
kink
tail
predomin
fetal
malform
seen
group
includ
anuri
hydrocephali
exencephali
micrognathiabrachygnathia
anophthalmiamicrophthalmia
shorten
trunk
anal
atresia
protrud
tongu
matern
development
toxic
observ
hsa
control
indic
toxic
directli
attribut
protein
content
development
toxic
data
rat
infus
singl
day
period
present
tabl
control
anim
receiv
singl
day
infus
hetastarch
gkg
dam
treat
hetastarch
neither
mean
fetal
weight
percentag
fetus
extern
malform
significantli
differ
control
interv
data
shown
gd
day
similar
indic
toxic
induc
treatmentrel
attribut
colloid
properti
howev
rat
infus
gkgday
gd
bore
malform
pup
litter
statist
signific
increas
rate
respect
signific
increas
percentag
malform
pup
born
dam
infus
mgkgday
observ
interv
exposur
earli
screen
level
infus
studi
conduct
singl
day
gestat
use
litter
per
group
absenc
statist
signific
regard
pairwis
comparison
versu
salin
function
small
number
litter
also
reduc
intens
fetal
examin
screen
studi
complet
evalu
fetus
would
includ
viscer
skelet
examin
definit
studi
typic
perform
howev
development
toxic
includ
alter
fetal
weight
addit
malform
possibl
obviat
statist
issu
combin
fetal
weight
data
fourday
span
gd
gd
time
period
preced
full
function
chorioallanto
placenta
comparison
potenti
development
toxic
combin
gd
hetastarchtr
group
includ
total
litter
treatment
group
total
fetus
hetastarchtr
dam
fetus
dam
hetastarch
fetus
g
significantli
heavier
group
g
analyz
dunnett
test
p
analysi
demonstr
development
toxic
effect
treatment
relat
osmol
hboc
fetal
weight
consid
sensit
endpoint
development
toxic
show
prechorioallanto
placenta
period
fetus
experienc
development
toxic
even
though
extern
malform
observ
treatment
gd
absenc
extern
malform
fetus
dam
treat
gd
like
due
normal
redistribut
matern
hboccontain
blood
within
maternalfet
interfac
occur
time
rat
chorioallanto
placenta
rat
develop
ectoplacent
cone
begin
becom
vascular
fetal
side
allanto
arteri
gd
prior
time
howev
tissu
ectoplacent
cone
develop
sinusoid
becom
fill
matern
blood
divert
volum
matern
blood
away
invysp
shown
detail
microspher
data
buelkesam
et
al
reduct
flow
invysp
like
suffici
reduc
impact
hboc
membran
extent
fetal
bodi
weight
affect
determin
whether
matern
development
toxic
observ
follow
infus
could
attribut
chang
oncot
pressur
rat
hemodilut
infus
mlkg
gkg
mlkg
salin
gd
tabl
data
indic
matern
weight
gain
day
infus
euthanasia
gd
markedli
lower
hemodilut
dam
infus
g
compar
hemodilut
dam
infus
equival
volum
salin
g
net
bodi
weight
gain
weight
gain
minu
weight
gravid
uteru
group
similar
salin
control
group
lower
matern
weight
gain
attribut
high
rate
embryoleth
lower
fetal
bodi
weight
observ
group
overt
sign
matern
toxic
observ
hemodilut
dam
infus
includ
redden
bodi
area
red
urin
addit
mean
number
viabl
fetus
g
compar
g
mean
fetal
weight
g
compar
g
group
lower
salineinfus
control
mean
litter
percentag
extern
malform
group
extern
malform
observ
fetus
born
hemodilut
anim
infus
salin
malform
consist
primarili
microphthalmia
cephalocel
second
hemodilut
studi
hemodilut
dam
infus
salin
hetastarch
gkg
pbh
gd
dosag
use
first
hemodilut
studi
matern
development
toxic
data
associ
group
present
tabl
neither
matern
development
toxic
observ
hemodilut
anim
infus
salin
hetastarch
howev
hemodilut
dam
infus
pbh
gain
significantli
less
weight
g
g
day
infus
euthanasia
gd
hemodilut
dam
infus
salin
hetastarch
g
g
respect
net
bodi
weight
gain
pbh
group
similar
salin
control
group
lower
matern
weight
gain
attribut
high
rate
embryoleth
lower
fetal
bodi
weight
observ
pbh
group
overt
sign
matern
toxic
hemodilut
group
infus
gkg
pbh
similar
observ
treatment
group
pbh
infus
hemodilut
dam
led
reduct
number
viabl
fetus
well
reduct
fetal
weight
litter
hemodilut
anim
mean
number
viabl
fetus
per
litter
mean
fetal
weight
reduc
infus
pbh
infus
salin
hetastarch
mean
litter
percentag
extern
malform
increas
hemodilut
dam
infus
gkg
pbh
wherea
incid
extern
malform
low
fetus
hemodilut
dam
infus
salin
hetastarch
malform
observ
pbh
group
fetus
consist
primarili
microphthalmia
hydrocephali
thu
pbh
result
similar
teratogen
profil
indic
hemoglobin
compon
essenti
observ
toxic
protein
dna
level
measur
embryo
invvi
expos
variou
concentr
present
tabl
protein
dna
level
significantli
decreas
doserespons
fashion
indic
interfer
tabl
matern
development
toxic
observ
result
hemodilut
follow
infus
salin
purifi
bovin
hemoglobin
salin
mlkg
hetastarch
gkg
pbh
gkg
normal
nutrit
mechan
support
protein
dna
biosynthesi
studi
assess
endocytot
capac
measur
uptak
degrad
fitclabel
albumin
embryo
invvi
eef
medium
tabl
demonstr
decreas
clearanc
protein
invvi
posit
correl
observ
percentag
viabl
embryo
fitc
clearanc
viscer
yolk
sac
extraembryon
fluid
fig
r
respect
furthermor
concentr
glutathion
measur
order
determin
development
toxic
attribut
part
increas
oxid
stress
level
glutathion
embryo
unchang
dose
examin
fig
level
glutathion
invvi
decreas
slightli
fig
indic
seem
affect
invvi
embryo
proper
data
insuffici
discern
oxid
stress
studi
malform
fetus
reduc
fetal
viabil
matern
toxic
observ
matern
infus
investig
defin
time
embryotox
reveal
malform
fetus
observ
matern
infus
primarili
gd
time
period
coincid
appear
earli
function
rat
invvi
gd
addit
rather
abrupt
disappear
malform
expos
litter
gd
concurr
develop
chorioallanto
placenta
rat
becom
well
establish
gd
histiotroph
mechan
transport
nutrient
cargo
invvi
differ
chorioallanto
placenta
work
countercurr
exchang
substanc
close
appos
matern
embryon
circul
advers
embryon
effect
produc
chorioallanto
placenta
fulli
function
embryotox
effect
appear
relat
impair
invvi
function
fitcalbumin
uptak
dna
content
studi
also
indic
earli
exposur
embryo
impair
endocytot
capac
invvi
thu
singleday
infus
data
vitro
embryo
exposur
data
consist
hypothesi
earli
develop
invvi
target
organ
toxic
reduc
nutritionstarv
pregnant
rat
mous
embryo
earli
period
organogenesi
previous
link
product
malform
speci
also
consist
find
hboctreat
litter
report
addit
interfer
invvi
function
remaind
gestat
would
expect
diminish
transfer
nutrient
embryo
could
account
fetal
weight
decrement
seen
hboctreat
group
must
point
cellfre
hemoglobin
hb
toxic
adult
anim
much
hb
toxic
due
perturb
redox
balanc
ferrou
ion
fe
ii
heme
moieti
oxid
ferric
ion
fe
iii
presenc
oxygen
gener
varieti
reactiv
oxygen
speci
ro
peroxid
review
young
embryo
howev
exist
hypox
state
establish
uteroplacent
circul
subsequ
oxygen
enrich
form
chorioallanto
placenta
two
tempor
distinct
gestat
mileston
increas
physiolog
exchang
nutrient
gase
mother
embryo
amount
oxygen
reach
embryo
increas
morpholog
embryon
mitochondria
chang
handl
increas
oxygen
exposur
effici
without
toxic
effect
hboc
due
creation
ro
would
expect
effect
embryo
would
increas
concomitantli
elev
oxygen
level
reach
embryo
subsequ
establish
chorioallanto
placenta
case
howev
advers
effect
embryo
decreas
chorioallanto
placenta
form
suggest
hbassoci
toxic
due
ro
use
variou
control
group
support
propos
mode
development
toxic
first
lack
development
toxic
hetastarch
control
group
demonstr
development
toxic
mere
result
imbal
oncot
pressur
must
due
separ
properti
polym
hemoglobin
compon
second
lack
development
toxic
infus
human
serum
albumin
indic
development
impact
due
high
protein
concentr
ad
matern
blood
volum
third
hemodilut
experi
investig
possibl
development
toxic
could
secondari
anemia
increas
circul
blood
volum
pregnant
rat
fetal
outcom
hemodilut
rat
infus
howev
differ
substant
fetal
outcom
nonhemodilut
rat
togeth
control
indic
development
toxic
result
increas
oncot
pressur
caus
increas
blood
volum
colloid
properti
fourth
development
toxic
result
infus
pbh
show
effect
caus
associ
larg
molecular
weight
protein
hemoglobin
given
observ
possibl
like
molecul
poison
invvi
eg
trypan
blue
concanavalin
lead
fetal
malform
inde
mechan
action
rodent
differ
anatomi
function
vestigi
human
vy
suggest
mechan
may
relev
human
develop
like
eutherian
mammal
human
possess
welldefin
yolk
sac
earli
postimplant
develop
organogenesi
yolk
sac
endoderm
epithelium
polar
similar
epithelia
endocytos
nutrient
materi
vy
lumen
especi
first
trimest
prior
full
activ
placent
function
unlik
rodent
human
yolk
sac
membran
never
becom
directli
appos
chorion
outer
embryon
membran
within
conceptu
resid
matern
uterin
wall
uterin
lumen
mean
human
yolk
sac
membran
function
placenta
sens
abl
transfer
nutrient
matern
conceptu
circul
furthermor
human
yolk
sac
invert
encompass
embryo
mean
materi
origin
human
blood
hboc
first
must
diffus
activ
transport
spheric
yolk
sac
lumen
prior
endocytos
polar
yolk
sac
endothelium
yolk
sac
remain
small
rel
size
develop
major
organogenesi
stage
embryo
suggest
surfac
area
avail
transport
human
embryo
small
compar
rodent
base
consider
believ
unlik
interfer
human
vy
function
contribut
hemoglobin
embryotox
elucid
potenti
risk
development
toxic
human
safeti
test
conduct
use
anim
model
reli
upon
invert
yolk
sac
embryon
nutrit
rodent
lagomorph
reli
invert
yolk
sac
earli
gestat
inappropri
model
assess
development
toxic
molecular
substanc
may
poison
invvi
among
commonli
use
experiment
model
use
safeti
test
nonhuman
primat
dog
invert
yolk
sac
studi
nonhuman
primat
lengthi
expens
pose
ethic
issu
use
gener
safeti
test
howev
substanti
amount
experi
use
dog
safeti
assess
studi
disciplin
signific
bodi
gener
toxicolog
physiolog
inform
develop
thu
development
toxic
studi
perform
canin
model
submit
companion
paper
could
verifi
development
toxic
rat
inde
due
sole
poison
invvi
fund
experi
suppli
biopur
dr
pearc
employe
biopur
dr
stump
holson
employe
wil
research
dr
harri
employe
univers
michigan
work
subcontractor
dr
watson
desesso
consult
biopur
transpar
document
associ
articl
found
onlin
version
